Drug repurposing strategies of relevance for Parkinson's disease
Abstract Parkinson's disease is a highly disabling, progressive neurodegenerative disease that manifests as a mix of motor and non‐motor signs. Although we are equipped with some symptomatic treatments, especially for the motor signs of the disease, there are still no established disease‐modify...
Saved in:
Main Authors: | Edward J. R. Fletcher (Author), Thomas Kaminski (Author), Gareth Williams (Author), Susan Duty (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Repurposing Strategy for Dimethyl Fumarate
by: Salvatore Giunta, et al.
Published: (2023) -
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
by: Norihiro Sakai, et al.
Published: (2023) -
Identification of high-affinity Monoamine oxidase B inhibitors for depression and Parkinson's disease treatment: bioinformatic approach of drug repurposing
by: Moyad Shahwan, et al.
Published: (2024) -
Strategies for drug repurposing against coronavirus targets
by: Poppy O. Smith, et al.
Published: (2022) -
A Single Domain Shark Antibody Targeting the Transferrin Receptor 1 Delivers a TrkB Agonist Antibody to the Brain and Provides Full Neuroprotection in a Mouse Model of Parkinson's Disease
by: Emily Clarke, et al.
Published: (2022)